Keyword: Thomson Reuters

News

KPMG Expects 2016 to become Another Record Year for M&A in the Pharmaceutical Industry

12.01.2016 - Globally, mergers and acquisitions at a value of USD 372 billion were recorded in the chemical and pharmaceutical sector in 2015. This amounts to an increase of 74% compared with...

News

Teva Makes $40 Billion Cash-and-Stock Bid for Mylan

22.04.2015 - In what is shaping up to be the global pharmaceutical industry's latest hostile takeover struggle, the world's largest generic drugmaker, Israel-based Teva, has made a bid for...

Markets & Companies

Potential In Eastern Europe

29.07.2014 - Over the past five years, emerging markets have experienced some of the highest pharmaceutical market growth rates, a trend that is expected to continue. Central Eastern Europe...

Markets & Companies

Opportunities Through Biotechnology

06.06.2014 - Latin America continues to be an area of rising investment for the pharmaceutical industry, with Brazil and Mexico leading the way. Not only is Latin America an attractive target...

Markets & Companies

Evolution of a Dynamic Healthcare Market

08.05.2014 - Changing Roles - China's far-reaching presence in the manufacture and supply of active pharmaceutical ingredients (APIs) around the world has long been known. However, with the...

Plant Construction & Process Technology

GDUFA’s Impact on the API Industry – an Update

02.04.2014 - The Price of Doing Business - Following the 2012 implementation of the Generic Drug User Fee Act (GDUFA), an article in CHEManager Europe's July/August 2013 edition about GDUFA's...

Plant Construction & Process Technology

Pharma In Africa

05.03.2014 - Up And Up - Long known for its struggles with infectious diseases and poverty, the continent of Africa is experiencing widespread economic growth. An increasing middle class and...

Plant Construction & Process Technology

U.S. API Manufacturing and Sustainability

16.01.2014 - Moving Away - Many would argue that the future of pharmaceutical growth in the coming years will come from emerging markets; U.S. pharma sales have been sluggish recently with a...